Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 83

1.

Prospects in folate receptor-targeted radionuclide therapy.

Müller C, Schibli R.

Front Oncol. 2013 Sep 24;3:249. doi: 10.3389/fonc.2013.00249. Review.

2.

Folate receptor-targeted radionuclide therapy: preclinical investigation of anti-tumor effects and potential radionephropathy.

Haller S, Reber J, Brandt S, Bernhardt P, Groehn V, Schibli R, Müller C.

Nucl Med Biol. 2015 Oct;42(10):770-9. doi: 10.1016/j.nucmedbio.2015.06.006. Epub 2015 Jun 11.

PMID:
26162583
3.

Preclinical development of small-molecular-weight folate-based radioconjugates: a pharmacological perspective.

Siwowska K, Müller C.

Q J Nucl Med Mol Imaging. 2015 Sep;59(3):269-86. Epub 2015 Jul 7. Review.

PMID:
26149341
4.

DOTA conjugate with an albumin-binding entity enables the first folic acid-targeted 177Lu-radionuclide tumor therapy in mice.

Müller C, Struthers H, Winiger C, Zhernosekov K, Schibli R.

J Nucl Med. 2013 Jan;54(1):124-31. doi: 10.2967/jnumed.112.107235. Epub 2012 Dec 12.

5.

Radioiodinated folic acid conjugates: evaluation of a valuable concept to improve tumor-to-background contrast.

Reber J, Struthers H, Betzel T, Hohn A, Schibli R, Müller C.

Mol Pharm. 2012 May 7;9(5):1213-21. doi: 10.1021/mp200511t. Epub 2012 Apr 17.

PMID:
22509996
6.

In vitro and in vivo evaluation of an innocuous drug cocktail to improve the quality of folic acid targeted nuclear imaging in preclinical research.

Müller C, Reber J, Schlup C, Leamon CP, Schibli R.

Mol Pharm. 2013 Mar 4;10(3):967-74. doi: 10.1021/mp300428p. Epub 2013 Feb 8.

PMID:
23394590
7.

177Lu-EC0800 combined with the antifolate pemetrexed: preclinical pilot study of folate receptor targeted radionuclide tumor therapy.

Reber J, Haller S, Leamon CP, Müller C.

Mol Cancer Ther. 2013 Nov;12(11):2436-45. doi: 10.1158/1535-7163.MCT-13-0422-T. Epub 2013 Sep 12.

8.

Folate based radiopharmaceuticals for imaging and therapy of cancer and inflammation.

Muller C.

Curr Pharm Des. 2012;18(8):1058-83. Review.

PMID:
22272825
9.

Folic acid conjugates for nuclear imaging of folate receptor-positive cancer.

Müller C, Schibli R.

J Nucl Med. 2011 Jan;52(1):1-4. doi: 10.2967/jnumed.110.076018. Epub 2010 Dec 13.

10.

Fluorine-18 click radiosynthesis and preclinical evaluation of a new 18F-labeled folic acid derivative.

Ross TL, Honer M, Lam PY, Mindt TL, Groehn V, Schibli R, Schubiger PA, Ametamey SM.

Bioconjug Chem. 2008 Dec;19(12):2462-70. doi: 10.1021/bc800356r.

PMID:
19053298
11.

Tumor targeting using 67Ga-DOTA-Bz-folate--investigations of methods to improve the tissue distribution of radiofolates.

Müller C, Vlahov IR, Santhapuram HK, Leamon CP, Schibli R.

Nucl Med Biol. 2011 Jul;38(5):715-23. doi: 10.1016/j.nucmedbio.2010.12.013. Epub 2011 Mar 3.

PMID:
21718947
12.

Preclinical Comparison of Albumin-Binding Radiofolates: Impact of Linker Entities on the in Vitro and in Vivo Properties.

Siwowska K, Haller S, Bortoli F, Benešová M, Groehn V, Bernhardt P, Schibli R, Müller C.

Mol Pharm. 2017 Feb 6;14(2):523-532. doi: 10.1021/acs.molpharmaceut.6b01010. Epub 2017 Jan 17.

PMID:
28094532
13.

Effects of antifolate drugs on the cellular uptake of radiofolates in vitro and in vivo.

Müller C, Brühlmeier M, Schubiger PA, Schibli R.

J Nucl Med. 2006 Dec;47(12):2057-64.

14.

The folate receptor as a rational therapeutic target for personalized cancer treatment.

Assaraf YG, Leamon CP, Reddy JA.

Drug Resist Updat. 2014 Oct-Dec;17(4-6):89-95. doi: 10.1016/j.drup.2014.10.002. Epub 2014 Oct 8. Review.

PMID:
25457975
16.

125I-Radioiodinated tyrosine-folate and tyrosine-click-folate.

Shan L.

Molecular Imaging and Contrast Agent Database (MICAD) [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2004-2013.
2012 May 20 [updated 2012 Jun 27].

17.

Improved PET imaging of tumors in mice using a novel (18) F-folate conjugate with an albumin-binding entity.

Fischer CR, Groehn V, Reber J, Schibli R, Ametamey SM, Müller C.

Mol Imaging Biol. 2013 Dec;15(6):649-54. doi: 10.1007/s11307-013-0651-x.

PMID:
23760583
18.

In vivo imaging of folate receptor positive tumor xenografts using novel 68Ga-NODAGA-folate conjugates.

Fani M, Tamma ML, Nicolas GP, Lasri E, Medina C, Raynal I, Port M, Weber WA, Maecke HR.

Mol Pharm. 2012 May 7;9(5):1136-45. doi: 10.1021/mp200418f. Epub 2012 Apr 23.

PMID:
22497506
19.

[18F]fluoro-deoxy-glucose folate: a novel PET radiotracer with improved in vivo properties for folate receptor targeting.

Fischer CR, Müller C, Reber J, Müller A, Krämer SD, Ametamey SM, Schibli R.

Bioconjug Chem. 2012 Apr 18;23(4):805-13. doi: 10.1021/bc200660z. Epub 2012 Mar 13.

PMID:
22372827
20.

(64)Cu- and (68)Ga-Based PET Imaging of Folate Receptor-Positive Tumors: Development and Evaluation of an Albumin-Binding NODAGA-Folate.

Farkas R, Siwowska K, Ametamey SM, Schibli R, van der Meulen NP, Müller C.

Mol Pharm. 2016 Jun 6;13(6):1979-87. doi: 10.1021/acs.molpharmaceut.6b00143. Epub 2016 May 4.

PMID:
27145400

Supplemental Content

Support Center